|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Excise taxes on products | |||||
| Net revenues (Notes 5 & 11) | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Marketing, administration and research costs (Notes 3, 4, 11 & 18) | |||||
| Amortization of intangibles | |||||
| Impairment of goodwill (Note 4) | |||||
| Operating income | |||||
| Interest expense, net (Note 13) | |||||
| Pension and other employee benefit costs (Note 12) | |||||
| Earnings before income taxes | |||||
| Provision for income taxes (Note 10) | |||||
| Impairment related to the RBH equity investment (Note 5) | |||||
| Equity investments and securities (income)/loss, net | |||||
| Net earnings | |||||
| Net earnings attributable to noncontrolling interests | |||||
| Net earnings attributable to PMI | |||||
| Per share data (Note 9): | |||||
| Basic earnings per share (in dollars per share) | |||||
| Diluted earnings per share (in dollars per share) | |||||
Loading...
